Common therapeutic advances for Duchenne muscular dystrophy (DMD)
A Salmaninejad, Y Jafari Abarghan… - International Journal …, 2021 - Taylor & Francis
Background and purpose: Duchenne muscular dystrophy (DMD), a lethal X-linked recessive
muscle dystrophy, is resulted in by different mutations including mostly frame-shifting gross …
muscle dystrophy, is resulted in by different mutations including mostly frame-shifting gross …
Ixazomib, an oral proteasome inhibitor, exhibits potential effect in dystrophin‐deficient mdx mice
MLJ Micheletto, TA Hermes… - International journal …, 2021 - Wiley Online Library
Dystrophin deficiency makes the sarcolemma fragile and susceptible to degeneration in
Duchenne muscular dystrophy. The proteasome is a multimeric protease complex and is …
Duchenne muscular dystrophy. The proteasome is a multimeric protease complex and is …
[HTML][HTML] Early administration of L‐arginine in mdx neonatal mice delays the onset of muscular dystrophy in tibialis anterior (TA) muscle
RWR Dudley, AS Comtois, DH St‐Pierre… - FASEB …, 2021 - ncbi.nlm.nih.gov
Duchenne muscular dystrophy (DMD) is a genetic disorder that results in the absence of
dystrophin, a cytoskeletal protein. Individuals with this disease experience progressive …
dystrophin, a cytoskeletal protein. Individuals with this disease experience progressive …
[引用][C] Optimisation d'un milieu de culture sans sérum pour l'expansion de cellules musculaires humaines
A Côté - 2021 - Université Laval